Skip to main content

Thor Medical

Thor Medical ASA is a Norwegian clinical-stage radiopharmaceutical technology company developing alpha emitters for targeted cancer therapy. The company utilizes proprietary extraction technology to produce thorium-228 and radium-224 isotopes from natural thorium for use in targeted radionuclide therapies. Main revenue drivers currently comprise development partnerships, isotope supply agreements, and capital markets financing as production technology scales. Thor Medical targets radiopharmaceutical developers, biopharmaceutical companies, and clinical research institutions globally. The company holds a specialized niche position in raw material production for next-generation alpha-emitting radiotherapeutics. Headquartered in Oslo, Norway, Thor Medical ASA is listed on Oslo Bors.

6 of the funds FundTelligence covers report a position in Thor Medical.

Legal name
Thor Medical ASA
Sector
Health Care
Country
Norway
Funds holding it
6

Funds holding Thor Medical

Loading...